Murid herpesvirus-4 lacking thymidine kinase reveals route-dependent requirements for host colonization
Open Access
- 1 June 2009
- journal article
- research article
- Published by Microbiology Society in Journal of General Virology
- Vol. 90 (6), 1461-1470
- https://doi.org/10.1099/vir.0.010603-0
Abstract
Gammaherpesviruses infect at least 90 % of the world's population. Infection control is difficult, in part because some fundamental features of host colonization remain unknown, for example whether normal latency establishment requires viral lytic functions. Since human gammaherpesviruses have narrow species tropisms, answering such questions requires animal models. Murid herpesvirus-4 (MuHV-4) provides one of the most tractable. MuHV-4 genomes delivered to the lung or peritoneum persist without lytic replication. However, they fail to disseminate systemically, suggesting that the outcome is inoculation route-dependent. After upper respiratory tract inoculation, MuHV-4 infects mice without involving the lungs or peritoneum. We examined whether host entry by this less invasive route requires the viral thymidine kinase (TK), a gene classically essential for lytic replication in terminally differentiated cells. MuHV-4 TK knockouts delivered to the lung or peritoneum were attenuated but still reached lymphoid tissue. In contrast, TK knockouts delivered to the upper respiratory tract largely failed to establish a detectable infection. Therefore TK, and by implication lytic replication, is required for MuHV-4 to establish a significant infection by a non-invasive route.This publication has 33 references indexed in Scilit:
- In vivo imaging of murid herpesvirus-4 infectionJournal of General Virology, 2009
- Multiple Functions for ORF75c in Murid Herpesvirus-4 InfectionPLOS ONE, 2008
- An Essential Role for the Proximal but Not the Distal Cytoplasmic Tail of Glycoprotein M in Murid Herpesvirus 4 InfectionPLOS ONE, 2008
- Recombinant gp350 Vaccine for Infectious Mononucleosis: A Phase 2, Randomized, Double‐Blind, Placebo‐Controlled Trial to Evaluate the Safety, Immunogenicity, and Efficacy of an Epstein‐Barr Virus Vaccine in Healthy Young AdultsThe Journal of Infectious Diseases, 2007
- Evidence for a Multiprotein Gamma-2 Herpesvirus Entry ComplexJournal of Virology, 2007
- Murine Gammaherpesvirus-68 Inhibits Antigen Presentation by Dendritic CellsPLOS ONE, 2007
- IgG Fc Receptors Provide an Alternative Infection Route for Murine Gamma-Herpesvirus-68PLOS ONE, 2007
- Glycosaminoglycan Interactions in Murine Gammaherpesvirus-68 InfectionPLOS ONE, 2007
- Immune Mechanisms in Murine Gammaherpesvirus-68 InfectionViral Immunology, 2005
- Epstein-Barr virus: exploiting the immune systemNature Reviews Immunology, 2001